Victory Capital Management’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,023
Closed -$319K 2569
2020
Q3
$319K Sell
3,023
-1,193
-28% -$147K ﹤0.01% 2139
2020
Q2
$1.08M Sell
4,216
-4,252
-50% -$1.62M ﹤0.01% 1693
2020
Q1
$3.77M Buy
8,468
+3,971
+88% +$2.12M ﹤0.01% 1356
2019
Q4
$3.04M Buy
4,497
+4,253
+1,743% +$2.13M ﹤0.01% 1354
2019
Q3
$90K Sell
244
-25
-9% -$8.13K ﹤0.01% 2470
2019
Q2
$48K Buy
+269
New +$55.9K ﹤0.01% 1737

Other funds holding NXTC

Victory Capital Management's NXTC Position: Q4 2020 in Review

Victory Capital Management sold out of NextCure (NXTC) in Q4 2020, closing a stake of 3,023 shares — an estimated $319K sold.

Victory Capital Management first reported a position in NXTC in Q2 2019 and held it in 6 quarters. The position peaked at $3.77M in Q1 2020. 83 funds tracked by Wall St. Rank hold NXTC as of Q4 2020.

  • Victory Capital Management reported no remaining NextCure position as of Q4 2020 after selling out during the quarter.
  • Victory Capital Management sold 3,023 NextCure shares in Q4 2020, an estimated $319K.
  • Victory Capital Management first reported a position in NextCure in Q2 2019 and held it in 6 quarters.
  • Victory Capital Management's NextCure position peaked at $3.77M in Q1 2020.
  • 83 funds tracked by Wall St. Rank held NextCure as of Q4 2020.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.